No abstract available
Keywords:
Tumor mutational burden; immune checkpoint inhibitor (ICI); inter-assay variability; whole exome sequencing (WES).
MeSH terms
-
Biomarkers, Tumor / metabolism
-
Humans
-
Immunotherapy / methods*
-
Mutation
-
Neoplasms / genetics
-
Neoplasms / pathology
-
Neoplasms / therapy*
-
Patient Selection*